Oncolytics Biotech

0 followers


Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called REOLYSIN® for the treatment of solid tumors and hematological malignancies.

Industries

Headquarters

Calgary, Canada

Employees

11-50

Links

Org chart

Matt Coffey
President & CEO

Matt Coffey

Collapse
Amy Levin
Vice President Clinical Operations
Allison Hagerman
VP, Product Development
Mary Ann Dillahunty
Vice President, Intellectual Property
Richard Trauger
Executive Director Translational Science